T. Roihu and A. L. Kariniemi, “Demodex Mites in Acne Rosacea,” Journal of Cutaneous Pathology, Vol. 25, No. 10, 1998, pp. 550-552. http://dx.doi.org/10.1111/j.1600-0560.1998.tb01739.x
 T. Jansen, U. Kastner, A. Kreuter and P. Altmeyer, “Rosacea-Like Demodicidosis Associated with Aquired Immunodeficiency Syndrome,” British Journal of Dermatology, Vol. 144, No. 1, 2001, pp. 139-142. http://dx.doi.org/10.1046/j.1365-2133.2001.03794.x
 E. F. Rostan, H. V. De Buys, D. L. Madey and S. R. Pinnell, “Evidence Supporting Zinc as an Important Antioxidant for Skin,” International Journal of Dermatology, Vol. 41, No. 9, 2002, pp. 606-615.
 K. E. Sharquie and K. K. Al-Azzawi, “Intralesional Therapy of Cutaneous Leishmaniasis with 2% Zinc Sulfate Solution,” Journal of Pan-Arab League of Dermatologists, Vol. 7, No. 2, 1996, pp. 41-49.
 I. G. Al-Tereihi, “Topical 10% Zinc Sulphate Solution in the Treatment of Superficial Fungal Infections,” A Thesis Submitted to the Iraqi Board for Medical Specializations, Dermatology and Venereology, 2006.
 K. E. Sharquie, W. S. Al-Dori, I. K. Sharquie and A. A. Al-Nuaimy, “Treatment of Pityriasis Versicolor with Topical 15% Zinc Sulfate Solution,” 15th Congress of the European Academy of Dermatology and Venereology, 2006.
 K. E. Sharquie, R. A. Najim, I. B. Farjou and D. J. Al-Timimi, “Oral Zinc Sulphate in the Treatment of Acute Cutaneous Leishmaniasis,” Clinical and Experimental Dermatology, Vol. 26, 2001, pp. 21-25. http://dx.doi.org/10.1046/j.1365-2230.2001.00752.x
 K. E. Sharquie, A. A. Noaimi and M. M. Al-Salih, “Topical Therapy of Acne Vulgarisusing 2% Tea Lotion in Comparison with 5% Zinc Sulphate Solution,” Saudi Medical Journal, Vol. 29, 2008, pp. 1757-1761.
 P. M. Mahjan, V. H. Jadhav, A. H. Patki, D. G. Jogaikar and J. M. Mehta, “Oral Zinc Therapy in Recurrent Erythema Nodosum Leprosum: A Clinical Study,” Indian Journal of Leprosy, Vol. 66, 1994, pp. 51-57.
 F. Al-Gurairi, M. M. Al-Waiz and K. E. Sharquie, “Oral Zinc Sulphate in the Treatment of Recalcitrant Viral Warts: Randomizd Placebo-Controlled Clinical Trial,” British Journal of Dermatology, Vol. 146, No. 3, 2002, pp. 423-431. http://dx.doi.org/10.1046/j.1365-2133.2002.04617.x
 O. J. Clermensen and J. Siggaard, “Psoriatic Arthritis Treated with Zinc Sulphate,” British Journal of Dermatology, Vol. 103, No. 4, 1980, pp. 411-415. http://dx.doi.org/10.1111/j.1365-2133.1980.tb07 264.x
 I. R. Record, “Protection by Zinc against UVA and UVB Induce Cellular and Genomic Damage in Vivo and in Vitro,” Biological Trace Element Research, Vol. 53, No. 1-3, 1996, pp. 19-25.
 S. K. Katiyar, “Green Tea Polyphenols Treatment to Human Skin Prevent Formation of Ultraviolet Light B-Induced Pyrimidine Dimmers in DNA,” Clinical Cancer Research, Vol. 6, No. 10, 2000, pp. 3864-3869.
 K. Mutasunaga, T. W. Klein and H. Fridman, “Legionella Pneumophila Replication in Macrophages Inhibited by Selective Immunomodulatory Effect on Cytokine Formation by Epigallcatechingallat a Major from of Tea Catechines,” Infection and Immunity, Vol. 69, No. 6, 2001, pp. 3947-3953.